Loading... Please wait... Loading... Please wait...
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings pag...
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...
SAN FRANCISCO, June 04, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and preven...
SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent...
Amalgamated Bank lowered its holdings in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 6.5% in the 4th quarter, according to its most recent 13F filing with the Securities ...
iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q1 2024 Earnings Conference Call May 2, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, IR Quentin Blackford - President and CEO Brice B...
SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predic...
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities...
NEW YORK, NY / ACCESSWIRE / April 8, 2024 / If you suffered a loss on your iRhythm Technologies, Inc. (NASDAQ:IRTC) investment and want to learn about a potential recovery under the federal securities...
